TopQ Cut-Off Determination Study
TopQ Cut-off Determination Study
1 other identifier
observational
10
1 country
1
Brief Summary
To determine optimal cut-off value for TopQ cut-off.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 2, 2013
CompletedFirst Posted
Study publicly available on registry
April 5, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedJune 7, 2022
June 1, 2022
4 months
April 2, 2013
June 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retinal Thickness
Day 1
Eligibility Criteria
Sujects that have no known ocular pathologies
You may qualify if:
- No known ocular pathologies
You may not qualify if:
- Any known ocular pathologies
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Topcon Medical Systems, Inc.
Oakland, New Jersey, 07436, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Sinai, PhD
Director of Clinical Marketing
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 2, 2013
First Posted
April 5, 2013
Study Start
February 1, 2013
Primary Completion
June 1, 2013
Study Completion
November 1, 2013
Last Updated
June 7, 2022
Record last verified: 2022-06